TBK1 and hepatocellular carcinoma: After knockdown or overexpression of TBK1 in HCC cells, the cells were treated with a series of doses of molecularly-targeted drugs to determine the effect of TBK1 in HCC cell death after treatment with molecularly-targeted drugs.